In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...

The UK’s largest listed companies are turning their heads towards the glimmer of the Nasdaq after growing impatient at the ...

AstraZeneca PLC (NASDAQ: AZN) ranks among the stocks to benefit from an onshoring boom. AstraZeneca PLC (NASDAQ:AZN) ...

Revenue from oncology products made up 43 per cent of Astrazeneca's revenue in the first half of 2025, up 15 per cent year on ...

AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ...

Total revenue rose 11 per cent to $28bn (£12.98bn) in the first half of the year, driven by double-digit growth in Oncology ...

The company didn’t share specific data for the molecule, gefurulimab, but said it hit all endpoints in the Phase III PREVAIL ...

The American president claims that tariffs will encourage more European and Japanese companies to build factories in the US, ...

The announcement of a 15% tariff on pharmaceutical imports to the U.S. from the European Union may have not been the ideal ...

Baghdad (IraqiNews.com) – The Iraqi Ministry of Health mentioned on Sunday that the agreement with Sanofi, a French ...

Likewise, India's Sona Comstar entered China through a $20-million joint venture to produce driveline systems and EV ...

Aspiration is terrific, but Labour's bravado about Britain being the fastest growing economy in the G7 was always hooey.